Novotech Receives CRO Leadership Award for Exceeding Customer Expectations

CHICAGO, IL, Jun 23, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and Life Science Leader CRO Leadership Award for exceeding customer expectations, at Drug Information Association 2022 (DIA 2022). Novotech CEO Dr. […]

NTT DOCOMO and NTT to Collaborate on 6G Experimental Trials with World-leading Mobile Technology Vendors

TOKYO, Jun 6, 2022 – (JCN Newswire via SEAPRWire.com) – NTT DOCOMO, INC. (DOCOMO) and Nippon Telegraph and Telephone Corporation (NTT) announced today that they will collaborate with world-leading mobile technology vendors Fujitsu, NEC, and Nokia to conduct experimental trials of new mobile communications technologies for the targeted commercial launch of 6G services by around […]

Fujitsu, NTT DOCOMO and NTT to start joint trials towards practical applications for 6G

TOKYO, Jun 6, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu today announced that it will start collaboration with NTT DOCOMO, INC. (hereinafter DOCOMO)(1) and Nippon Telegraph and Telephone Corporation (hereinafter NTT)(2) to conduct joint trials towards the realization of practical applications for 6G. In the joint trials, the partners will utilize radio waves in […]

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

SYDNEY, Jun 6, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO22 “Accelerating clinical development in China and the US”. Register here https://asco22.endpts.com/TUESDAY, JUNE 711:00am – 11:45am ET (1:00 – 1:45 local time)Novotech Booth at […]

Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and Regulatory Strategy for China and US

SYDNEY, Jun 2, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, has sponsored expert panels at the Pre-ASCO China Summit 2022 bringing together leaders in oncology drug development in China and the US. The Pre-ASCO series was watched by […]

Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials

SYDNEY, May 12, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO China Summit 2022 event titled: Go/No Go Decisions Based on Early Phase Oncology Trials (‘The Summit’). The Summit will feature insights […]

Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC

ADELAIDE, AUS, Apr 19, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence. Avance Clinical has undergone significant expansion in recent years, including new offices in […]

Avance Clinical Announces New Office Opening in Melbourne

MELBOURNE, Mar 31, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Melbourne to support its growing clinical team in the greater Melbourne region. The Avance Clinical team in Melbourne The formal opening event was attended by all the […]

Avance Clinical Announces New Office Opening in Sydney

SYDNEY, Mar 2, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the greater Sydney region. Avance Clinical’s CEO Yvonne Lungershausen said: “We continue to offer a hybrid working environment for […]

Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report

SYDNEY, Feb 9, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, has been recognized as a top 10 CRO in the 2021 CenterWatch Global Site Relationship Benchmark Survey. Report available here. https://novotech-cro.com/news/novotech-recognized-top-10-cro-centerwatch-site-relationship-benchmarking-report CenterWatch, established in 1994, is a global benchmarking authority for the clinical trials sector. The benchmarking […]

Eisai: Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM

Cambridge, MA, Jan 28, 2022 – (JCN Newswire via SEAPRWire.com) – Biogen Inc. and Eisai Co., Ltd. (Tokyo, Japan) today announced additional details about the Phase 4 post-marketing confirmatory study, ENVISION, of ADUHELM (aducanumab-avwa) 100 mg/mL injection for intravenous use in early Alzheimer’s disease, including details of the study’s goal for diverse enrollment and primary […]

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

ADELAIDE, AUS, Jan 18, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m. Avance […]